학술논문

Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome after CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial
Document Type
Article
Source
In: Journal of Clinical Oncology. (Journal of Clinical Oncology, 10 March 2021, 39(8):920-930)
Subject
Language
English
ISSN
15277755
0732183X